Dedalus Group
VC Fund
Firenze, Italy
Dedalus Group is a VC fund in Firenze focused on Health Care and Health Diagnostics. Established in Florence in 1990, Dedalus Spa is today at the head of a leading national healthcare software industrial Group, with many important roles in all public and private health market segments, a sector that is of strategic importance for the national economy. Since 2006 Dedalus has been pursuing a project for bringing together the bestcompanies of the Italian healthcare ICT: Avelco, Ingenius, Intema Sanità, Metafora Informatica, Millennium, Radiosity, Sicilia Sistemi Tecnologie, Sago Informatica Sanitaria, Synapsis and Eurosoft Informatica Medica, and the 7 companies connected to the same. This process was carried out with the objective of overcoming the existing market fragmentation, and becoming an important reference point of excellence, with important research and development investment capabilities: an information technology company focused on healthcare, but also capable of competing on the international markets. Since 2009, Dedalus began the international penetration based on the best strategic product (Interoperability and Cooperation Platform), named X1.V1. With over 200 products installed in Italy and abroad, Dedalus designs solutions for the image diagnostic sector, and has an important role also in Hospital-Territory integration systems, with a presence in almost all the Regions implementing important projects of interoperability and cooperation among the various healthcare establishments, such as hospitals, general practitioners and ASL units. Dedalus is capable of consistently strengthening its position in each of these segments thanks to its innovative approach, based on the development of software aimed at ensuring interoperability and cooperation among general medicine systems and hospital systems, facilitating the optimisation of administrative management, as well as the provision of the best healthcare, thanks to a constant real time exchange of fundamental patient data, during all the stages of their life: from birth, to the growing up stage, to maturity and old age.Dedalus Group is a Italian healthcare IT systems company.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Dedalus Group invests in
Stages Dedalus Group invests in
Countries Dedalus Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Chris Masci
|
|||
Claudio Cricelli
|
|||
Giorgio Moretti
|
|||
Lapo Bertini
|
|||
Maciej Gorczynski
|
|||
| See all 7 contacts → | |||
Investment Focus
Industry
- Health Care 1 (100%)
- Health Diagnostics 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chris Masci
Vice President of Business Development
|
Vice President of Business Development | Total investments: 0 | Find email | |
|
Claudio Cricelli
President
|
President | Total investments: 0 | Find email | |
|
Giorgio Moretti
Dedalus Holding President
|
Dedalus Holding President | Total investments: 0 | Find email | |
|
Lapo Bertini
Director of Interoperability Product Management
|
Director of Interoperability Product Management | Total investments: 0 | Find email | |
|
Maciej Gorczynski
Frontend Developer
|
Frontend Developer | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ObvioHealth
|
ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data.Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed toinclude site visits, our application allows for continuous data collection in between visits to the clinic.By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials.The result: robust data collection, increased compliance, faster recruitment and improved time to completion.To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps.Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video.Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials. | $19.3M / Series B / Jun 08, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dedalus Group invest in?
Dedalus Group invests primarily in Health Care and Health Diagnostics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dedalus Group?
Public channels for Dedalus Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Dedalus Group?
The team at Dedalus Group includes Chris Masci (Vice President of Business Development), Claudio Cricelli (President) and Giorgio Moretti (Dedalus Holding President), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
